NRC Health Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
NRC Health (NRC) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $252.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-08.
Discontinued › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2019-03-08
- NRC Health noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2016 was $252.00K, a 90.96% decline from fiscal 2015.
- NRC Health noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2015 was $2.79M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month |
|---|---|
| 2016-12-31 | $252.00K 10-K · filed 2019-03-08 |
| 2015-12-31 | $2.79M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |